ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,043Medicare Part D Prescriptions Filled, Including Refills

Rank: 285 out of 2035

$418K Total Retail Price of All Prescriptions

Rank: 444 out of 2035

320 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 320 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 320 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

0% of this provider’s 7,446 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LISINOPRIL 376 343 1 3
LEVOTHYROXINE SODIUM 359 329 2 4
SIMVASTATIN 327 318 3 1
DONEPEZIL HCL 259 259 4 24
WARFARIN SODIUM 251 244 5 11
CITALOPRAM HBR 238 228 6 20
FUROSEMIDE 222 209 7 7
OMEPRAZOLE 206 195 8 5
POTASSIUM CHLORIDE 204 197 9 18
METOPROLOL TARTRATE 183 158 10 8
NAMENDA 182 182 11 37
HYDROCODONE-ACETAMINOPHEN 171 134 S3 12 2
FLUTICASONE PROPIONATE 128 119 13 29
LOSARTAN POTASSIUM 127 127 14 15
TRAMADOL HCL 111 95 15 19
DIVALPROEX SODIUM 107 107 16 75
ALENDRONATE SODIUM 105 105 17 27
TRAZODONE HCL 105 94 17 50
MELOXICAM 104 94 19 56
SERTRALINE HCL 103 94 20 23
METOPROLOL SUCCINATE 103 102 20 16
AMLODIPINE BESYLATE 99 95 22 6
RISPERIDONE 91 91 23 68
ALLOPURINOL 90 87 24 34
CARVEDILOL 89 87 25 22
ISOSORBIDE MONONITRATE ER 84 73 26 32
SPIRONOLACTONE 82 82 27 65
TAMSULOSIN HCL 81 81 28 25
HYDRALAZINE HCL 79 76 29 45
ATENOLOL 79 79 29 10
ZOLPIDEM TARTRATE 72 50 31 21
QUETIAPINE FUMARATE 66 66 32 70
METHYLPREDNISOLONE 66 58 32 125
ATORVASTATIN CALCIUM 60 47 34 13
PREDNISONE 59 52 35 36
METFORMIN HCL 55 51 36 9
NITROFURANTOIN 52 52 37 359
AZITHROMYCIN 51 46 38 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.